Schizophrenia in a Molecular Age: Review of Psychiatry, vol. 18
J Clin Psychiatry 2000;61:877-878 [book review]
© Copyright 2014 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
From our regular book review column.
The reader should remember the expression, “do not judge a book by its cover,” or, in this case, its title or the book-jacket blurb either. The latter contains the statement that “Clinicians will learn new treatments to offer, including medication and psychological and psychosocial interventions, which are significantly better than previous treatment options,” which is not the case. This slim volume is about schizophrenia, but has very little to do with molecular biology as I, at least, expected and hoped it would when I first examined it.